Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BMS-986165 (brolucizumab? note: BMS-986165 corresponds to deucravacitinib?; but based on naming, BMS-986165 is a placeholder) against pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-12-20